Financial Performance - Operating revenue for Q1 2024 was CNY 80,785,174.94, representing a year-on-year increase of 14.31% from CNY 70,673,548.81 in Q1 2023[12] - Net profit attributable to shareholders for Q1 2024 was CNY 5,541,687.61, down 9.83% from CNY 6,145,705.81 in the same period last year[12] - The company reported a basic earnings per share of ¥0.03 for Q1 2024, unchanged from Q1 2023[39] - The company’s total comprehensive income for Q1 2024 was 3,815,580.87, compared to 4,992,807.40 in Q1 2023[42] - Net profit for Q1 2024 was 3,815,580.87, down 23.5% from 4,992,807.40 in Q1 2023[41] Assets and Liabilities - Total assets as of March 31, 2024, were CNY 882,748,547.92, a decrease of 2.23% compared to the end of 2023[12] - The total liabilities to total assets ratio (consolidated) was 11.56%, slightly down from 11.93% at the end of 2023[12] - Total current assets increased from ¥470,372,791.94 on March 31, 2023, to ¥507,031,174.82 on December 31, 2023, representing an increase of approximately 7%[29] - Total non-current assets increased from ¥412,375,755.98 to ¥395,874,645.42, reflecting a decrease of about 4%[30] - Total liabilities decreased from ¥102,054,327.09 to ¥107,750,985.84, a decrease of approximately 5%[31] Cash Flow - The net cash flow from operating activities was negative CNY 30,175,996.67, a decline of 214.17% compared to negative CNY 9,604,904.95 in Q1 2023[12] - Cash flow from operating activities showed a net outflow of -30,175,996.67 in Q1 2024, compared to -9,604,904.95 in Q1 2023[43] - Cash inflow from operating activities totaled 79,890,134.02, an increase from 76,543,555.39 in Q1 2023[43] - Total cash outflow from operating activities was 110,066,130.69, up from 86,148,460.34 in Q1 2023[43] - The company reported a cash and cash equivalents balance of 286,177,373.32 at the end of Q1 2024, down from 332,540,975.85 at the end of Q1 2023[44] Research and Development - Research and development expenses increased by 65.13% to CNY 5,680,082.74, reflecting the company's commitment to enhancing R&D efforts[14] - Research and development expenses increased to ¥5,680,082.74 in Q1 2024, compared to ¥3,439,668.91 in Q1 2023, reflecting a growth of 65.2%[36] - Research and development expenses increased significantly to 1,614,119.81, up 135.9% from 686,109.94 in Q1 2023[41] Shareholder Information - The total number of unrestricted shares is 62,810,237, representing 34.85% of the total share capital[19] - The total number of restricted shares is 117,395,663, accounting for 65.15% of the total share capital[19] - The largest shareholder, Liu Tiebin, holds 86,214,900 shares, which is 47.84% of the total shares[21] - The total share capital of the company is 180,205,900 shares[20] - The company has a total of 126,018,979 shares held by the top ten shareholders, representing 69.93% of the total shares[22] Investment Activities - The company's investment income surged by 4,230.66% to CNY 192,866.25 due to increased investment in financial products[14] - Cash received from investment redemption increased by 387.55% to CNY 31,690,566.07, indicating improved liquidity management[15] - Investment activities resulted in a net cash outflow of -5,646,984.51 in Q1 2024, compared to -42,546,809.59 in Q1 2023[44] - The company reported cash received from the acquisition of subsidiaries at $3,000,000.00, a significant increase from $100,000.00[46] Legal and Compliance - The company has not reported any pledges or judicial freezes on shares held by major shareholders[23] - There are no significant related party transactions or external guarantees reported during the period[25] - The company has not faced any legal disputes or penalties during the reporting period[25]
绿亨科技(870866) - 2024 Q1 - 季度财报